Similar articles

• Paliperidone palmitate - review of the efficacy, safety and cost of a new second-generation depot antipsychotic medication.

  Citrome L. Citrome L. Int J Clin Pract. 2010 Jan;64(2):216-39. doi: 10.1111/j.1742-1241.2009.02240.x. Epub 2009 Nov 3. Int J Clin Pract. 2010. PMID: 19886879 Review.
• Second-generation long-acting injectable antipsychotic agents: an overview.

  [No authors listed] [No authors listed] Drug Ther Bull. 2012 Sep;50(9):102-5. doi: 10.1136/dtb.2012.08.0127. Drug Ther Bull. 2012. PMID: 22966099 Review.
• The cost-effectiveness of paliperidone extended release in Spain.

  Treur M, Baca E, Bobes J, Cañas F, Salvador L, Gonzalez B, Heeg B. Treur M, et al. J Med Econ. 2012;15 Suppl 1:26-34. doi: 10.3111/13696998.2012.734884. Epub 2012 Oct 23. J Med Econ. 2012. PMID: 23016569
• What are the nursing implications when using paliperidone prolonged release for people with schizophrenia.

  Jones A. Jones A. J Psychiatr Ment Health Nurs. 2008 Dec;15(10):792-9. doi: 10.1111/j.1365-2850.2008.01299.x. J Psychiatr Ment Health Nurs. 2008. PMID: 19012670
• Practical guidance for dosing and switching paliperidone palmitate treatment in patients with schizophrenia.

  Gopal S, Gassmann-Mayer C, Palumbo J, Samtani MN, Shiwach R, Alphs L. Gopal S, et al. Curr Med Res Opin. 2010 Feb;26(2):377-87. doi: 10.1185/03007990903482772. Curr Med Res Opin. 2010. PMID: 20001492 Review.